Palo Alto, Calif.-based Stanford Medicine's operating income for the nine months ending May 31 was 24 percent above the same period in 2022, according to a July 7 filing.
The $351.9 million figure was despite expenses increasing 8.5 percent over the corresponding period in 2021-22. Total revenue for the period was $5.8 billion.
The system has an "AA" rating with Fitch.